ALF-ONE : ALFuzosin ONcE Daily
NCT00280605
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Hyperplasia
Interventions
DRUG:
Alfuzosin
Sponsor
Sanofi